Informa
Antibody Engineering & Therapeutics US
2024年12月15-18日
米国、カリフォルニア州サンディエゴ、Marriott Marquis San Diego Marina 対面形式で開催: 2024年12月15-18日

PRE-CONFERENCE WORKSHOPS (pm only) and TRAINING COURSE (full day - PT (Pacific Time, GMT-08:00)

PRE-CONFERENCE WORKSHOPS (pm only) and TRAINING COURSE (full day - PT (Pacific Time, GMT-08:00)

search
8:00am - 9:00am60 mins
Training Course Registration
    OPTIONAL PRE-CONFERENCE TRAINING COURSE 9:00 am - 5:00 pm -and PRE-CONFERENCE WORKSHOPS 1:00 PM - 5:00 PM
    9:00am - 5:00pm480 mins
    Training Course: Introduction to Antibody Engineering
    Introduction to Antibody Engineering
    • David Bramhill, PhD - Consultant, Bramhill Biological Consulting, LLC
    10:00am - 12:00pm120 mins
    Early Career Scientists Session
    Early Career Scientists Session
      1:00pm - 1:15pm15 mins
      Workshop 1: Quantitative Systems Pharmacology in Antibody Development
      Co-Chairs' Remarks: Quantitative Systems Pharmacology in Antibody Development
      • Karl Dane Wittrup, Ph.D. - C.P. Dubbs Professor in Chemical Engineering and Biological Engineering, Massachusetts Institute of Technology
      • Stephen Beers, PhD - Professor of Immunology and Immunotherapy, University of Southampton
      1:00pm - 1:15pm15 mins
      Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
      Co-Chairs' Remarks: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
      • Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
      • Jonathan Sockolosky, PhD - Senior Director, CSO Partner Team, Curie.Bio
      1:15pm - 1:45pm30 mins
      Workshop 1: Quantitative Systems Pharmacology in Antibody Development
      Advances in Understanding Cell Signaling in Immunotherapeutics
      • Douglas Lauffenburger, PhD - Ford Professor of Bioengineering, Massachusetts Institute of Technology
      1:15pm - 1:45pm30 mins
      Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
      Antibody Therapeutics: Riding the Pendulum of Innovation
      • Lazar Bojic, Ph.D. - Vice President of Investor Network, Curie.Bio
      1:45pm - 2:15pm30 mins
      Workshop 1: Quantitative Systems Pharmacology in Antibody Development
      Mathematical Modeling of Response to Immunotherapy in Pancreatic Ductal Adenocarcinoma
      • Daniel Bergman, Ph.D. - Postdoctoral Fellow, Johns Hopkins Medicine
      1:45pm - 2:15pm30 mins
      Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
      Protecting Innovations: IP Strategies for Antibody Therapeutics in a Competitive Market
      • Robin Silva - Consulting Patent Attorney, Xencor
      2:15pm - 2:45pm30 mins
      Workshop 1: Quantitative Systems Pharmacology in Antibody Development
      Designing Clinically Effective Antibody Drug Conjugates in Solid Tumors Using Quantitative Systems Pharmacology
      • Greg Thurber, Ph.D. - Assistant Professor, Chemical and Biomedical Engineering, University of Michigan
      2:15pm - 2:45pm30 mins
      Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
      Investing in Antibody-based Therapeutics
      • Sarah Hymowitz - Partner, The Column Group
      2:45pm - 3:15pm30 mins
      Workshop 1: Quantitative Systems Pharmacology in Antibody Development
      Networking Refreshment Break
        2:45pm - 3:15pm30 mins
        Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
        Networking Refreshment Break
          3:15pm - 3:45pm30 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Bridging the In Vitro to In Vivo Gap for T-cell Engagers Using QSP Modeling
          • David Flowers, Ph.D. - Director, ABS, Certara
          3:15pm - 3:45pm30 mins
          Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
          Tackling the Impossible Task of Project Selection in An Early Stage Biotech Startup
          • Alexey Lugovskoy, Ph.D. - President and CEO, Diagonal Therapeutics
          3:45pm - 4:15pm30 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Modeling Immunological Synapse Formation Initiated by Bispecific T cell Engagers: What, Why and How
          • Yanguang Cao, PhD - Associate Professor, University of North Carolina at Chapel Hill
          3:45pm - 4:15pm30 mins
          Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
          Carving out a Path to Differentiation in a Crowded Therapeutics Market
          • Shelley Force Aldred, Ph.D. - CEO, Rondo Therapeutics
          4:15pm - 4:45pm30 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Comparison of Cancer-targeting and Stromal-targeting Antibody Drug Conjugates Using Bystander QSP models
          • Ezgi Wood, PhD - Senior Research Investigator, QSP, Bristol Myers Squibb
          4:15pm - 4:45pm30 mins
          Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
          Panel Discussion
          • Jonathan Sockolosky, PhD - Senior Director, CSO Partner Team, Curie.Bio
          • Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
          4:45pm - 5:00pm15 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Concluding Remarks
            4:45pm - 5:00pm15 mins
            Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
            Concluding Remarks
              5:00pm - 5:05pm5 mins
              Close of Workshops and Training Course
                Next MAIN CONFERENCE 12/6

                * 不測の事態により、事前の予告なしにプログラムが変更される場合があります。